
作為一家從事生命科學(xué)和體外診斷行業(yè)的俄羅斯私有企業(yè),XEMA有限公司(原Xema-Medica有限公司)始建于1993年2月,總部設(shè)在莫斯科。 
公司從一開(kāi)始開(kāi)展人類(lèi)抗原合成的代工業(yè)務(wù),到現(xiàn)在公司已經(jīng)成為世界上的腫瘤標(biāo)志物抗原生產(chǎn)企業(yè)。我們廣泛收集雜交瘤細(xì)胞的業(yè)務(wù)確保我們能夠生產(chǎn)出大量用于體外診斷的純化單克隆抗體 
截止到目前, 我們非常自豪可以在幾個(gè)主要研究課題的重點(diǎn)研究工作上保持著非常高的科研水準(zhǔn):
- 生物化學(xué)和人類(lèi)腫瘤標(biāo)志物和獸藥標(biāo)志物免疫學(xué) [癌胚抗原(CEA),糖類(lèi)抗原(CA 125),糖類(lèi)抗原(CA 19 – 9),糖類(lèi)抗原(CA 72 – 4),附膜蛋白(MUC1),細(xì)胞角蛋白等];
- 食物抗原的免疫化學(xué)(特別是谷物,肉類(lèi)和魚(yú)類(lèi)醇溶蛋白);
- 真菌性抗原的研究以及對(duì)食品和環(huán)境真菌污染評(píng)估的免疫開(kāi)發(fā)研究。
XEMA新產(chǎn)品列表:
產(chǎn)品目錄編號(hào)  | 產(chǎn)品名稱  | 檢測(cè)的數(shù)量  | 產(chǎn)品英文名稱  | 樣品量,微升  | 靈敏度  | 階段編號(hào)  | 培育時(shí)間,分鐘  | 培育溫度  | 保質(zhì)期,月  | 方法  | 版本  | CE注冊(cè)號(hào)  | 
K930  | SULPHONAMIDE EIA  | 96  | Sulphonamides are widely used in agriculture as potent and effective f>  | 50  | 0,5 ?g/l  | 2  | /60/60/10-20'  | 37?C  | 12  | ???  | 002  | 0  | 
K902  | Laevomycetin (Chloramphenicol) EIA  | 96  | Laevomycetin (Chloramphenicol) is a potent antibiotic drug which is wi>  | 50  | 0,035 ?g/l  | 1  | //60/25-35'  | 37 ?C  | 12  | ???  | 909  | 0  | 
K101M  | Toxoplasma IgM EIA  | 96  | TToxoplasmosis is a widespread infection caused by the intracellular p>  | 10  | K  | 2  | 60//30/10-20'  | 37 ?C  | 12  | ???  | 906  | 0  | 
K102M  | Rubella IgM EIA  | 96  | 
  | 10  | K  | 2  | 60//30/10-20'  | 37 C  | 12  | EIA  | 003  | 0  | 
K103M  | Cytomegalovirus IgM EIA  | 96  | 
  | 10  | K  | 2  | 60//30/10-20'  | 37 C  | 12  | EIA  | 906  | 0  | 
K104M  | HSV 1, 2 IgM EIA  | 96  | 
  | 10  | K  | 2  | 60//30/10-20'  | 37 C  | 12  | EIA  | 906  | 0  | 
K151C  | Parvo-IgG EIA  | 96  | Parvovirus genus includes several specii, the canidae Parvovirus (CPV)>  | 100*  | 5 U/ml  | 2  | 30//30/10-20'  | 37 ?C  | 12  | ???  | 711  | 0  | 
K152C  | CDV-IgG EIA  | 96  | canidae/mustelidae Distermer disease is caused by a virus of the Pramy>  | 100*  | 10 U/ml  | 2  | 30//30/10-20'  | 37 ?C  | 12  | ???  | 711  | 0  | 
K244  | CA72-4 EIA  | 96  | CA72-4 is a carbohydrate antigen (an epitope) with a MM ca. 230 kD ass>  | 10  | 2 U/ml  | 2  | 120//60/10-20'  | 37 ?C  | 12  | ???  | 901  | 0  | 
K279K  | free K-chain EIA  | 96  | Apart from normal immunoglobulins, free immunoglobulin light chains (k>  | 40*  | 1 ?g/ml  | 2  | 30//30/10-20'  | 37 ?C  | 18  | ???  | 000  | 0  | 
K279L  | free L-chain EIA  | 96  | Apart from normal immunoglobulins, free immunoglobulin light chains (k>  | 40*  | 0,1 ?g/ml  | 2  | 30//30/10-20'  | 37 ?C  | 18  | ???  | 000  | 0  | 
KQ23  | PrenaQon-Control  | 2 levels x 2 pcs; 1 ml  | 
  | 
  | 
  | 0  | ///-'  | 0  | 36  | 0  | 510  | NO  | 
E235  | ?-HCG LIFA  | 96  | Thyroid stimulating hormone (TSH) is a glycoprotein with molecular wei>  | 50  | 0,5 ng/ml  | 1  | //60/10-'  | 37?C  | 0  | ????  | 901  | 0  | 
E238  | PAPP-A LIFA  | 96  | Thyroid stimulating hormone (TSH) is a glycoprotein with molecular wei>  | 50  | 20 mIU/l  | 1  | //60/10-'  | 37?C  | 0  | ????  | 901  | 0  | 
K236  | CYFRA 21-1 EIA  | 96  | Antigen CYFRA 21-1 is an established name for the epitopes expressed o>  | 50  | 1 ng/ml  | 1  | //30/10-20'  | 37 ?C  | 12  | ???  | 912  | 0  | 
K174CF  | Nematoda IgG-CF EIA  | 96  | 
  | 100*  | K  | 2  | 30//30/10-20'  | 37 C  | 12  | 
  | 002  | 0  | 
K175CF  | Eucestoda IgG-CF EIA  | 96  | 
  | 100*  | K  | 2  | 30//30/10-20'  | 37 C  | 12  | 
  | 004  | 0  | 
K200S  | Specific IgE EIA  | 96  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | 50  | 0,1 IU/ml  | 3  | 60/60/30/10-20'  | 18-25?C  | 12  | ???  | 001  | 0  | 
K200SCB  | Specific IgE CB EIA  | 16  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | 0  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200SP  | Specific IgE P EIA  | 96  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | 0  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200ST  | Specific IgE T EIA  | 96  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | 0  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200STx  | Specific IgE-Tx EIA  | 40  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | *  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200SD1  | Specific IgE-D1 EIA  | 40  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | *  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200SE1  | Specific IgE-E1 EIA  | 40  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | *  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200SE2  | Specific IgE-E2 EIA  | 40  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | *  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200SGx  | Specific IgE-Gx EIA  | 40  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | *  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K200SW56  | Specific IgE-W56 EIA  | 40  | Specific IgE (sIgE) mediates type I (immediate) allergic reactions, wi>  | *  | 
  | 0  | ///-'  | 0  | 12  | ???  | 001  | 0  | 
K470  | CIC-  | 96x4  | Immune complexes are clusters of interlocking antigens and antibodies.>  | 20  | 0  | 1  | 120///-'  | 18-25?C  | 36  | ??  | 001  | 0  | 
K201N  | TSH-Neo EIA  | 96  | TSH-Neo ELISA is intended for the quantitative determination of Thyroi>  | 0  | 3 ?IU/ml  | 2  | 12-18 ????? (????)//60/10-20'  | 18-25?C  | 12  | ???  | 001  | 0  | 
#NBS  | 0  | 3 c 1  | 
  | 0  | 
  | 0  | ///-'  | 0  | 0  | 
  | 005  | 0  | 
K111  | Treponema pallidum EIA  | 96  | 
  | 40  | K  | 2  | 30//30/15-30'  | 37C  | 12  | 
  | 000  | 0  | 

電話
QQ咨詢
4006551678